Greenwood Capital Associates LLC Repligen Corp Transaction History

Greenwood Capital Associates LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$161.19 - $257.96 $562,553 - $900,280	-3,490 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$247.59 - $304.47 $14,855 - $18,268	60 Added 1.75%	3,490 $924,000
Q3 2021 Oct 27, 2021	BUY	$194.77 - $324.21 $20,840 - $34,690	107 Added 3.22%	3,430 $991,000
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $14,264 - $19,001	86 Added 2.66%	3,323 $663,000
Q1 2021 May 14, 2021	BUY	$180.37 - $226.26 $41,304 - $51,813	229 Added 7.61%	3,237 $629,000
Q4 2020 Feb 09, 2021	BUY	$148.08 - $206.57 $77,593 - $108,242	524 Added 21.1%	3,008 $576,000
Q3 2020 Nov 12, 2020	BUY	$122.51 - $158.27 $51,699 - $66,789	422 Added 20.47%	2,484 $366,000
Q2 2020 Aug 12, 2020	SELL	$94.33 - $140.48 $55,088 - $82,040	-584 Reduced 22.07%	2,062 $255,000
Q1 2020 May 12, 2020	SELL	$84.96 - $109.14 $11,979 - $15,388	-141 Reduced 5.06%	2,646 $255,000
Q4 2019 Feb 12, 2020	BUY	$73.84 - $93.08 $205,792 - $259,413	2,787 New	2,787 $257,000

493

54M

420K

85.3K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.48B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Greenwood Capital Associates LLC with notifications on news.